Financial Ratios GE HealthCare Technologies Inc.
Equities
GEHC
US36266G1076
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
90.28 USD | -0.38% | +3.22% | +16.76% |
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Profitability | |||||
Return on Assets | - | - | 6.91 | 5.88 | 6.15 |
Return on Total Capital | - | - | 10.93 | 8.9 | 10.42 |
Return On Equity % | - | - | 14.28 | 14.72 | 19.15 |
Return on Common Equity | - | - | 14.21 | 14.59 | 16.85 |
Margin Analysis | |||||
Gross Profit Margin % | 39.37 | 39.43 | 40.8 | 39.14 | 40.52 |
SG&A Margin | 21.64 | 18.88 | 20.27 | 19.74 | 19.27 |
EBITDA Margin % | 16.68 | 19.49 | 19.44 | 17.26 | 18.21 |
EBITA Margin % | 15.33 | 18.2 | 18.16 | 16.01 | 16.94 |
EBIT Margin % | 12.72 | 15.82 | 15.89 | 13.81 | 15.09 |
Income From Continuing Operations Margin % | 10.11 | 11.99 | 12.94 | 10.63 | 8.28 |
Net Income Margin % | 9.16 | 80.67 | 12.78 | 10.45 | 8.02 |
Net Avail. For Common Margin % | 9.93 | 11.69 | 12.68 | 10.35 | 7.1 |
Normalized Net Income Margin | 7.68 | 9.57 | 9.96 | 8.28 | 7.31 |
Levered Free Cash Flow Margin | - | - | 4.43 | 10.04 | 13.28 |
Unlevered Free Cash Flow Margin | - | - | 4.57 | 10.33 | 15.02 |
Asset Turnover | |||||
Asset Turnover | - | - | 0.7 | 0.68 | 0.65 |
Fixed Assets Turnover | - | - | 7.93 | 8.06 | 8.12 |
Receivables Turnover (Average Receivables) | - | - | 5.85 | 5.27 | 5.25 |
Inventory Turnover (Average Inventory) | - | - | 5.88 | 5.44 | 5.65 |
Short Term Liquidity | |||||
Current Ratio | - | 0.9 | 1.04 | 1.16 | 1.05 |
Quick Ratio | - | 0.52 | 0.62 | 0.74 | 0.74 |
Operating Cash Flow to Current Liabilities | - | 0.26 | 0.24 | 0.29 | 0.23 |
Days Sales Outstanding (Average Receivables) | - | - | 62.42 | 69.24 | 69.5 |
Days Outstanding Inventory (Average Inventory) | - | - | 62.05 | 67.05 | 64.57 |
Average Days Payable Outstanding | - | - | 79.73 | 88.02 | 94.02 |
Cash Conversion Cycle (Average Days) | - | - | 44.75 | 48.28 | 40.06 |
Long Term Solvency | |||||
Total Debt/Equity | - | 0.23 | 0.22 | 90.02 | 134.92 |
Total Debt / Total Capital | - | 0.23 | 0.22 | 47.37 | 57.43 |
LT Debt/Equity | - | 0.21 | 0.18 | 88.78 | 119.66 |
Long-Term Debt / Total Capital | - | 0.21 | 0.18 | 46.72 | 50.93 |
Total Liabilities / Total Assets | - | 38.2 | 35.78 | 65.17 | 77.48 |
EBIT / Interest Expense | 24.05 | 41.15 | 69.85 | 29.44 | 5.44 |
EBITDA / Interest Expense | 31.53 | 50.7 | 85.48 | 39.33 | 6.99 |
(EBITDA - Capex) / Interest Expense | 28.55 | 47.11 | 79.42 | 35.72 | 6.28 |
Total Debt / EBITDA | - | 0.01 | 0.01 | 2.55 | 2.6 |
Net Debt / EBITDA | - | -0.29 | -0.15 | 2.13 | 1.94 |
Total Debt / (EBITDA - Capex) | - | 0.01 | 0.01 | 2.81 | 2.9 |
Net Debt / (EBITDA - Capex) | - | -0.31 | -0.16 | 2.34 | 2.17 |
Growth Over Prior Year | |||||
Total Revenues, 1 Yr. Growth % | - | 3.19 | 2.45 | 4.3 | 6.6 |
Gross Profit, 1 Yr. Growth % | - | 3.34 | 6.01 | 0.07 | 10.35 |
EBITDA, 1 Yr. Growth % | - | 20.58 | 2.18 | -7.43 | 12.48 |
EBITA, 1 Yr. Growth % | - | 22.51 | 2.24 | -8.05 | 12.77 |
EBIT, 1 Yr. Growth % | - | 28.36 | 2.87 | -9.38 | 16.51 |
Earnings From Cont. Operations, 1 Yr. Growth % | - | 22.43 | 10.54 | -14.33 | -16.98 |
Net Income, 1 Yr. Growth % | - | 808.53 | -83.77 | -14.73 | -18.16 |
Normalized Net Income, 1 Yr. Growth % | - | 28.55 | 6.58 | -13.24 | -5.88 |
Diluted EPS Before Extra, 1 Yr. Growth % | - | - | - | - | -27.27 |
Accounts Receivable, 1 Yr. Growth % | - | - | 55.41 | 7.48 | 6.55 |
Inventory, 1 Yr. Growth % | - | - | 22.08 | 10.74 | -9.05 |
Net Property, Plant and Equip., 1 Yr. Growth % | - | - | 1.5 | 3.53 | 8.04 |
Total Assets, 1 Yr. Growth % | - | - | 8.59 | 4.68 | 17.85 |
Tangible Book Value, 1 Yr. Growth % | - | - | 52.55 | -359.71 | 41.8 |
Common Equity, 1 Yr. Growth % | - | - | 13.09 | -43.82 | -23.77 |
Cash From Operations, 1 Yr. Growth % | - | -15.18 | -4.74 | 31.49 | -0.57 |
Capital Expenditures, 1 Yr. Growth % | - | -9.89 | 2.11 | 28.1 | 24.84 |
Levered Free Cash Flow, 1 Yr. Growth % | - | - | - | 173.82 | 36.13 |
Unlevered Free Cash Flow, 1 Yr. Growth % | - | - | - | 171.71 | 49.67 |
Compound Annual Growth Rate Over Two Years | |||||
Total Revenues, 2 Yr. CAGR % | - | - | 2.82 | 3.37 | 5.44 |
Gross Profit, 2 Yr. CAGR % | - | - | 4.67 | 3 | 5.08 |
EBITDA, 2 Yr. CAGR % |